Dentists in Gretna, NE Accepting Medicare

4 Dentists found. Showing 1 - 4

Patrick J Cockerill, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 830 Village Sq, Gretna, NE 68028 Phone: 402-332-3946

Dr. Fionna Tay Gov, DMD Dentist Medicare: Medicare Enrolled Practice Location: 700 S Highway 6, Gretna, NE 68028 Phone: 402-332-3446

Jay Alan Kocian, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 20024 Glenmore Dr, Gretna, NE 68028 Phone: 402-916-9300    Fax: 402-916-9931

Dr. Hubble Vaughn Reichert, DDS Dentist Medicare: Medicare Enrolled Practice Location: 11812 Standing Stone Dr, Gretna, NE 68028 Phone: 402-905-2880    Fax: 402-905-2550

News Archive

Most Americans still don't draft advance directives or living wills

The Associated Press: "Five years after the court fight over allowing Terri Schiavo to die, most Americans still don't draft the legal documents that spell out how far caregivers should go to keep them alive artificially. Schiavo's life and death captivated the country and fueled conversations about the necessity of the documents, known as advance directives or living wills.

Boniva generics receive FDA approval for treatment, prevention of osteoporosis

The U.S. Food and Drug Administration today approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.

Call for clarification, education on enactment of new FSA restriction

A provision of health care reform could blindside consumers and create an administrative nightmare for providers and retailers as its January 1, 2011 implementation date draws closer. Without intervention, the Patient Protection and Affordable Health Care Act, passed earlier this year, will require consumers to obtain a physician's "prescription" in order to use their pre-tax flexible spending accounts (FSAs) to pay for over-the-counter (OTC) medicines other than insulin.

Par Pharmaceutical receives final ANDA approval for generic version of Trilipix

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fenofibric acid EQ 45 mg and EQ 135 mg delayed-release capsules.

Significant increases in IT use have not reduced drug review process

Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, published in the International Journal of Electronic Healthcare.

Read more Medical News

› Verified 6 days ago